Indiana Biosciences Research Institute Unveiled
Purdue University part of first industry-led collaborative life sciences research institute in the United States.

Molecular Modelling to Help Create Better, Safer Drugs
How our bodies break down the common drugs ibuprofen, diclofenac and warfarin is the subject of a new study from the University of Bristol.

ATARiS Informatics Platform Hits the Jackpot
ATARiS is one of several tools developed at the Broad Institute to precisely tune in to the signals within noisy datasets.

New Software Spots, Isolates Cyber-attacks to Protect Networked Control Systems
Software algorithm detects and isolates cyber-attacks on networked control systems that are becoming increasingly important to national infrastructure

Computational Tool Translates Complex Data into 2-Dimensional Images
May allow doctors to track progression of cancer, response to treatment, and risk of relapse.

Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
Assistant Professor at Northwestern Recognized for Cancer Diagnostics Research.

Launch of £90m Initiative in Big Data and Drug Discovery at Oxford University
'Big data' to revolutionise healthcare.

HealthLinkNow Integrates SBR Health
HLN and SBR announced HLN has selected SBR’s video call routing and management solution to manage virtual patient-provider visits on HLN’s telemedicine network.

Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines
NIAID-funded investigators develop interactive web applications to share data with peers.

Gifts to Boost University of Chicago as Hub for Biomedical 'Big Data'
Two major gifts will build momentum behind the University of Chicago’s leadership in biomedical computation.

Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.
Fragment Based de novo Ligand Design: A Valuable Optimisation Tool in Fragment Based Lead Discovery Peter Johnson, University of Leeds, speaking at Discovery Chemistry Congress 2012.
The Versatility of Fragment Screening Approaches and the Application of Fragment Binding Information in Durg Discovery Stefan Geschwindner, AstraZeneca, speaking at Discovery Chemistry Congress 2012.
Current Challenges in Fragment-Based Drug Discovery Roderick E Hubbard, University of York, speaking at Discovery Chemistry Congress 2012.
An Open Innovation Ecosystem for Drug Discovery Dr Michael Barnes, OI Pharma Partners Ltd., speaking at Discovery Chemistry Congress 2012.
Rationalizing ADME in the Current Regulatory and Business Environment Robert Guttendorf, Aclairo Pharmaceutical Development Group, speaking at ADME & Predictive Toxicology Europe
In Vitro, Ex Vivo and in Models to Develop New Therapies for Renal Diseases Frederick W. K. Tam, Imperial College London, speaking at ADME & Predictive Toxicology Europe 2012
Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe
In Silico Toxicology: Where are We at and Where are We Going? John C. Dearden, Liverpool John Moores University, speaking at ADME & Predictive Toxicology Europe 2012

<<	1 2 3 4	>>
Showing Results 11 - 20 of 39